Niren Thanky and Lynn LaPierre, consultants from Spencer Stuart, join Becker's Healthcare to discuss the biopharma and life sciences industry trends they are watching for in 2025. They delve into the impacts of AI, GLP-1 drugs, private equity investment, and more, exploring their implications for leadership and the broader industry.
This episode is sponsored by Spencer Stuart.
